Kinexum :: G. Alexander Fleming, MD



	Dr. Fleming helped shape regulatory policy, review process, and reviewer professionalism for over a decade as review, leader, and innovator at FDA

Home : Leadership : Fleming

G. Alexander Fleming, MD

President and Chief Executive Officer

Medical training and laboratory research experience at Emory, Vanderbilt, and National Institutes of Health
Board certified in Internal Medicine and Endocrinology and Metabolism
Extensive clinical experience and FDA regulatory responsibilities for metabolic and endocrine disorders, growth and development, nutrition, lipid-lowering compounds, and reproductive disorders
Represented FDA in international arena with an extended assignment to World Health Organization, Geneva and three ICH working groups
Chaired professional education and training for FDA's Center for Drug Evaluation & Research (CDER)
Co-founded and served as editor in chief of the CDER's Virtual Journal of Drug Evaluation
Major contributor to FDA's Good Review Practice (GRP) initiative
Frequent invited lecturer at international symposia
Invited editorialist of the New England Journal of Medicine and commentator on National Public Radio
Member of numerous scientific advisory boards and expert committees

Additional resources, publications, and other information from Dr. Fleming are available in the Kinexum Information Center.



	Lead author of Optimizing Therapeutic Development in Diabetes Co-Editor of Natural Products: Drug Discovery, Therapeutics, and Preventive Medicine.